STIGALL L. JEREMY has filed 38 insider transactions across 1 company since December 2023.
Most recent transaction: a option exercise of 30995 shares of ClearPoint Neuro, Inc. ($CLPT) on March 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 30995 | $0.00 | 123,633.0000 | 28,428,176 | 33.46% | 0.11% |
| March 12, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 15151 | $11.53 | 108,482.0000 | 28,428,176 | 12.25% | 0.05% |
| March 12, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 30995 | $0.00 | 30,995.0000 | 28,428,176 | 50.00% | 0.11% |
| March 11, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 8291 | $0.00 | 0.0000 | 28,428,176 | 100.00% | 0.03% |
| March 11, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 8291 | $0.00 | 95,862.0000 | 28,428,176 | 9.47% | 0.03% |
| March 11, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 3224 | $11.62 | 92,638.0000 | 28,428,176 | 3.36% | 0.01% |
| March 6, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 17778 | $0.00 | 0.0000 | 28,428,176 | 100.00% | 0.06% |
| March 6, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 17778 | $0.00 | 94,484.0000 | 28,428,176 | 23.18% | 0.06% |
| March 6, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 6913 | $10.00 | 87,571.0000 | 28,428,176 | 7.32% | 0.02% |
| March 3, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 8856 | $0.00 | 81,212.0000 | 28,428,176 | 12.24% | 0.03% |
| March 3, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 8856 | $0.00 | 35,424.0000 | 28,428,176 | 20.00% | 0.03% |
| March 3, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 4506 | $8.84 | 76,706.0000 | 28,428,176 | 5.55% | 0.02% |
| Feb. 17, 2026 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Restricted Stock Units | 51546 | $0.00 | 51,546.0000 | 28,428,176 | 9999.99% | 0.18% |
| Dec. 31, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Common Stock | 1 | $9.57 | 72,356.0000 | 28,428,176 | 0.00% | 0.00% |
| June 30, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Common Stock | 1608 | $10.15 | 72,355.0000 | 27,980,184 | 2.27% | 0.01% |
| June 10, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 3561 | $13.29 | 70,747.0000 | 27,980,184 | 4.79% | 0.01% |
| March 12, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 5545 | $13.18 | 74,308.0000 | 27,617,415 | 6.94% | 0.02% |
| March 12, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 15497 | $0.00 | 61,990.0000 | 27,617,415 | 20.00% | 0.06% |
| March 12, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 15497 | $0.00 | 79,853.0000 | 27,617,415 | 24.08% | 0.06% |
| March 11, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 8292 | $0.00 | 8,291.0000 | 27,617,415 | 50.00% | 0.03% |
| March 11, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 8292 | $0.00 | 67,323.0000 | 27,617,415 | 14.05% | 0.03% |
| March 11, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 2967 | $12.70 | 64,356.0000 | 27,617,415 | 4.41% | 0.01% |
| March 6, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 17777 | $0.00 | 65,392.0000 | 27,617,415 | 37.33% | 0.06% |
| March 6, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 6361 | $13.19 | 59,031.0000 | 27,617,415 | 9.73% | 0.02% |
| March 6, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 17777 | $0.00 | 17,778.0000 | 27,617,415 | 50.00% | 0.06% |
| March 3, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Restricted Stock Units | 44280 | $0.00 | 44,280.0000 | 27,617,415 | 9999.99% | 0.16% |
| Feb. 22, 2025 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 908 | $16.72 | 47,615.0000 | 27,617,415 | 1.87% | 0.00% |
| Dec. 31, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Common Stock | 251 | $4.53 | 48,523.0000 | 27,588,819 | 0.52% | 0.00% |
| Aug. 20, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 420 | $11.26 | 48,272.0000 | 27,588,812 | 0.86% | 0.00% |
| June 28, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Common Stock | 3500 | $4.58 | 48,692.0000 | 27,416,345 | 7.74% | 0.01% |
| June 10, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 2502 | $5.74 | 45,192.0000 | 27,416,345 | 5.25% | 0.01% |
| May 20, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Restricted Stock Units | 77487 | $0.00 | 77,487.0000 | 27,416,345 | 9999.99% | 0.28% |
| March 11, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | A | Restricted Stock Units | 16583 | $0.00 | 16,583.0000 | 24,652,729 | 9999.99% | 0.07% |
| March 6, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Common Stock | 8889 | $0.00 | 50,874.0000 | 24,652,729 | 21.17% | 0.04% |
| March 6, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | M | Restricted Stock Units | 8889 | $0.00 | 35,555.0000 | 24,652,729 | 20.00% | 0.04% |
| March 6, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | Chief Business Officer | F | Common Stock | 3180 | $6.24 | 47,694.0000 | 24,652,729 | 6.25% | 0.01% |
| Feb. 22, 2024 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | GM, Biologics & Drug Delivery | F | Common Stock | 1039 | $7.49 | 41,985.0000 | 24,652,729 | 2.41% | 0.00% |
| Dec. 29, 2023 | ClearPoint Neuro, Inc. | $CLPT | STIGALL L. JEREMY | GM, Biologics & Drug Delivery | A | Common Stock | 378 | $5.77 | 43,024.0000 | 24,578,983 | 0.89% | 0.00% |